Joaquin Duato

Joaquin Duato, Chairman and CEO of Johnson & Johnson, joins to discuss the company's ambitious $55 billion U.S. investment commitment. He highlights innovations in medical devices and the integration of AI in accelerating cancer therapies. Duato also addresses the regulatory landscape, expressing confidence in U.S. innovation and talent. Insightful updates on talc litigation and J&J's financial health are shared, alongside their promising pipeline of products, showcasing the company’s strategic focus on long-term growth.

Joaquin Duato, Chairman and CEO of Johnson & Johnson, discusses the power of saying 'Yes' to new opportunities, the importance of trust in managers, and the value of personal experiences in shaping career success. They also explore internal mobility, imposter syndrome, leadership responsibilities, and the significance of a strong mission in healthcare.